An extraordinary General Meeting of PCI Biotech Holding ASA was held on 14 September 2018 at 10:00 CEST at Oslo Cancer Cluster Innovation Park.
Please find attached the protocol of the extraordinary General Meeting.
An Ordinary General Meeting of PCI Biotech Holding ASA was held on 29 May 2018 at 10:00 CET at Oslo Cancer Cluster Innovation Park.
Please find attached the protocol of the Ordinary General Meeting.
An Ordinary General Meeting of PCI Biotech Holding ASA was held on 29 May 2017 at 10:00 CET at Oslo Cancer Cluster Innovation Park.
Please find attached the protocol of the Ordinary General Meeting.
An extraordinary General Meeting of PCI Biotech Holding ASA was held on 8 December 2016 at 09:00 CET at Oslo Cancer Cluster Innovation Park.
Please find attached the protocol of the extraordinary General Meeting.
An Ordinary General Meeting of PCI Biotech Holding ASA was held on 19 May 2016 at 10:00 CET at Quality Hotel Expo, Fornebu. Please find attached the protocol of the Ordinary General Meeting.
Lysaker, 12 May 2015
The Annual General Meeting in PCI Biotech Holding ASA took place on 12 May 2015. All propositions according the call were approved.
A new Board of Directors was elected and consists of the following members until next Annual General Meeting:
* Erling Øverland, chairman
* Kjetil Taskén, member
* Hilde H. Steineger, member
* Hans Peter Bøhn, member (New)
* Christina Herder, member (New)
Minutes from the Annual General Meeting is attached.
For further information, please contact
Ronny Skuggeda,CFO
E-mail: rs@pcibiotech.noOffice: +47 67 11 54 00
Mobile: +47 94 00 57 57
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
An Ordinary General Meeting of PCI Biotech Holding ASA was held on 13 May 2014 at 10:00 CET at Quality Hotel Expo, Fornebu. Please find attached the protocol of the Ordinary General Meeting.
An Ordinary General Meeting of PCI Biotech Holding ASA was held on 6 May 2013 at 10:00 CET at Quality Hotel Expo, Fornebu. Please find attached the protocol of the Ordinary General Meeting.
An Ordinary General Meeting of PCI Biotech Holding ASA was held on 25 April 2012 at 10:00 CET at the company’s premises in Strandveien 55, Lysaker. Please find atteched the protocol of the Ordinary General Meeting.
Oslo, Norway, April 13, 2011
An Ordinary General Meeting of PCI Biotech Holding ASA was held on 13 April 2011 at 10:00 CET at the company’s premises in Strandveien 55, Lysaker. Please find atteched the protocol of the Ordinary General Meeting.
Oslo, Norway, May 18, 2010
An Extraordinary General Meeting was held in PCI Biotech Holding ASA (“PCI Biotech”) on 18 May 2010. The Extraordinary General Meeting unanimously resolved a rights issue. The resolution was made in accordance with the proposal set forth in the notice of 27 April 2010, with the exception that the payment date for new shares was changed to 17 June 2010.
Please find attached the protocol of the Extraordinary General Meeting (pdf).
For further information, please contact:
Per Walday
CEO
Mobil: +47 91793429
E-mail: per.walday@pcibiotech.no
Oslo, Norway, April 27, 2010
An Ordinary General Meeting of PCI Biotech Holding ASA was held on 27 April 2010 at 9:30 CET at the company’s offices in Strandveien 55, Lysaker. Please find attached the protocol of the Ordinary General Meeting (pdf) in Norwegian.
For further information, please contact:
Per Walday
CEO
Mobil: +47 91793429
E-mail: per.walday@pcibiotech.no
Oslo, Norway, April 30, 2009
An Ordinary General Meeting of PCI Biotech Holding ASA was held on 30. April 2009 at 9:30 CET at the company’s offices in Hoffsveien 48, Oslo. Please find attached the protocol of the Ordinary General Meeting (pdf) in Norwegian.
For further information, please contact:
Per Walday
CEO
Mobil: +47 91793429
E-mail: per.walday@pcibiotech.no
Oslo, Norway, October 22, 2008
An Extraordinary General Meeting of PCI Biotech Holding ASA was held on 22 October 2008 at 9:00 CET at the company’s offices in Hoffsveien 48, Oslo. All the proposed resolutions were unanimously approved. Please find attached an english translation of the protocol of the Extraordinary General Meeting (pdf).
For further information, please contact:
Per Walday
CEO
Mobil: +47 91793429
E-mail: per.walday@pcibiotech.no